Should the primary focus of pre-diabetes treatment be glucose control or weight loss? Bartolome Burguera, MD, PhD, Chairman of Cleveland Clinic’s Endocrinology and Metabolism Institute, discusses the two different treatment scenarios.
Bartolome Burguera, MD, PhD, is new Chair of Cleveland Clinic’s Endocrinology and Metabolism Institute. ConsultQD sat down with Dr. Burguera to get to know this internationally recognized endocrinologist, and discuss his vision for the future of obesity and diabetes care.
Endocrinology & Metabolism Institute is partnering with Novo Nordisk to study the effectiveness of the health system’s employee health plan-sponsored integrated weight management program, with and without the use of medications.
With many first-line oral treatments for type 2 diabetes associated with weight gain, healthcare providers are faced with a therapeutic dilemma. Should they focus their efforts on improving patients’ glycemic control or helping these patients lose weight? A closer look at the dilemma, the drugs and the direction for better diabetes control.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Physicians often ask if they can fit weight counseling into a short office visit. The answer is YES. Information from a pre-visit questionnaire via the electronic medical record can help to facilitate that.
As the incidence of obesity increase, the healthcare system is taxed with caring for more patients struggling with cardiovascular disease, diabetes and other chronic conditions. At Cleveland Clinic, Bartolome Burguera, MD, PhD, is leading the charge for treating what is often the primary condition: obesity.
Shared medical appointments at the heart of a novel Cleveland Clinic program for morbidly obese patients who want to avoid bariatric surgery.